S. Ahtila

Statistics

Publications

Citations

260

H-Index

Active since

1994

Affiliations

Orion Corporation (Finland)(Current)

University of Helsinki

S. Ahtila is an author at Orion Corporation (Finland) specializing in dopaminergic pharmacology, medicine, and catechol-o-methyltransferase inhibition.

Publications per year

1994–1997

Publications

Effect of entacapone, a COMT inhibitor, on clinical disability and levodopa metabolism in parkinsonian patients

Seppo Kaakkola, H. Teräväinen, S. Ahtila et al. · Neurology · 1994 · 115 citations

Medicine, Pharmacology, Pharmacotherapy +17

Effect of Entacapone, a COMP Inhibitor, on the Pharmacokinetics and Metabolism of Levodopa After Administration of Controlled-Release Levodopa-Carbidopa in Volunteers

S. Ahtila, Seppo Kaakkola, A. Gordin et al. · Clinical Neuropharmacology · 1995 · 55 citations

Medicine, Pharmacokinetics, Pharmacology +12

Simultaneous MAO‐B and COMT inhibition in <scp>L</scp>‐dopa‐treated patients with parkinson's disease

Jukka Lyytinen, Seppo Kaakkola, S. Ahtila et al. · Movement Disorders · 1997 · 52 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Entacapone in combination with standard or controlled‐release levodopa/carbidopa: a clinical and pharmacokinetic study in patients with Parkinson's disease

Seppo Kaakkola, H. Teräväinen, S. Ahtila et al. · European Journal of Neurology · 1995 · 38 citations

Medicine, Pharmacokinetics, Pharmacotherapy +17

1–4 of 4